Bayberry Capital Partners’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-282,600
Closed -$4.64M 35
2026
Q1
$4.64M Sell
282,600
-25,664
-8% -$630K 1.44% 24
2025
Q4
$8.8M Buy
308,264
+126,100
+69% +$3.42M 2.79% 19
2025
Q3
$5.36M Hold
182,164
1.28% 25
2025
Q2
$5.25M Sell
182,164
-335,836
-65% -$9.93M 1.69% 21
2025
Q1
$18.1M Buy
518,000
+97,830
+23% +$3.99M 5% 7
2024
Q4
$18.7M Sell
420,170
-107,830
-20% -$4.41M 7.13% 4
2024
Q3
$24.1M Buy
+528,000
New +$21.4M 8.12% 3

Other funds holding QDEL

Bayberry Capital Partners's QDEL Position: Q2 2026 in Review

Bayberry Capital Partners sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 282,600 shares — an estimated $4.64M sold.

Bayberry Capital Partners first reported a position in QDEL in Q3 2024 and held it in 7 quarters. The position peaked at $24.1M in Q3 2024. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Bayberry Capital Partners reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Bayberry Capital Partners sold 282,600 QuidelOrtho shares in Q2 2026, an estimated $4.64M.
  • Bayberry Capital Partners first reported a position in QuidelOrtho in Q3 2024 and held it in 7 quarters.
  • Bayberry Capital Partners's QuidelOrtho position peaked at $24.1M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Bayberry Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.